HEADER DNA BINDING PROTEIN 29-NOV-22 8FB2 TITLE HUMAN RETENOID-RELATED ORPHAN RECEPTOR-GAMMA (RORC2) LIGAND-BINDING TITLE 2 DOMAIN IN COMPLEX WITH COMPOUND 8 ANDINDAZOLE ACID BOUND IN H12- TITLE 3 POCKET COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORC2, RORGAMMAT, STRUCTURE-BASED DESIGN, MACROCYCLIZATION, TOPICAL KEYWDS 2 DELIVERY, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 1 01-MAR-23 8FB2 0 JRNL AUTH M.E.SCHNUTE,J.I.TRUJILLO,K.L.LEE,R.UNWALLA,F.F.VAJDOS, JRNL AUTH 2 B.KAUPPI,P.NUHANT,A.C.FLICK,K.K.CROUSE,Y.ZHAO,A.SAMUEL, JRNL AUTH 3 V.LOMBARDO,A.P.TAYLOR,A.L.BRAULT,J.D.KNAFELS,M.L.VAZQUEZ, JRNL AUTH 4 G.BERSTEIN JRNL TITL MACROCYCLIC RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR JRNL TITL 2 C2 INVERSE AGONISTS. JRNL REF ACS MED.CHEM.LETT. V. 14 191 2023 JRNL REFN ISSN 1948-5875 JRNL PMID 36793423 JRNL DOI 10.1021/ACSMEDCHEMLETT.2C00500 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 22889 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.220 REMARK 3 FREE R VALUE TEST SET COUNT : 1195 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3046 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2059 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2894 REMARK 3 BIN R VALUE (WORKING SET) : 0.2039 REMARK 3 BIN FREE R VALUE : 0.2458 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.99 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4057 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 118 REMARK 3 SOLVENT ATOMS : 191 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.20300 REMARK 3 B22 (A**2) : 4.24240 REMARK 3 B33 (A**2) : 2.96060 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.87820 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.269 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.364 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.227 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.379 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.231 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4357 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5964 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1552 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 98 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 710 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4357 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 520 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4890 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.63 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.01 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FB2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000270325. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23071 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 97.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.36300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 5.9, 5 MM AMMONIUM REMARK 280 SULFATE, 300 MM MAGNESIUM CHLORIDE, 10% N,N-DIMETHYLFORMAMIDE, REMARK 280 AND 14% PEG-MME-5000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.84000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 256 REMARK 465 MET A 257 REMARK 465 PRO A 258 REMARK 465 THR A 508 REMARK 465 GLU A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 SER A 512 REMARK 465 PRO A 513 REMARK 465 VAL A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 SER A 517 REMARK 465 SER B 256 REMARK 465 MET B 257 REMARK 465 PRO B 258 REMARK 465 SER B 507 REMARK 465 THR B 508 REMARK 465 GLU B 509 REMARK 465 THR B 510 REMARK 465 GLU B 511 REMARK 465 SER B 512 REMARK 465 PRO B 513 REMARK 465 VAL B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 SER B 517 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 287 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 435 64.22 -114.45 REMARK 500 GLU B 435 63.30 -113.97 REMARK 500 REMARK 500 REMARK: NULL DBREF 8FB2 A 259 517 UNP P51449 RORG_HUMAN 259 517 DBREF 8FB2 B 259 517 UNP P51449 RORG_HUMAN 259 517 SEQADV 8FB2 SER A 256 UNP P51449 EXPRESSION TAG SEQADV 8FB2 MET A 257 UNP P51449 EXPRESSION TAG SEQADV 8FB2 PRO A 258 UNP P51449 EXPRESSION TAG SEQADV 8FB2 SER A 278 UNP P51449 CYS 278 ENGINEERED MUTATION SEQADV 8FB2 SER A 345 UNP P51449 CYS 345 ENGINEERED MUTATION SEQADV 8FB2 SER B 256 UNP P51449 EXPRESSION TAG SEQADV 8FB2 MET B 257 UNP P51449 EXPRESSION TAG SEQADV 8FB2 PRO B 258 UNP P51449 EXPRESSION TAG SEQADV 8FB2 SER B 278 UNP P51449 CYS 278 ENGINEERED MUTATION SEQADV 8FB2 SER B 345 UNP P51449 CYS 345 ENGINEERED MUTATION SEQRES 1 A 262 SER MET PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR SEQRES 2 A 262 GLU ILE GLU HIS LEU VAL GLN SER VAL SER LYS SER TYR SEQRES 3 A 262 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 4 A 262 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 5 A 262 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 6 A 262 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 7 A 262 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU SER GLN SEQRES 8 A 262 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 9 A 262 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 10 A 262 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 11 A 262 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 12 A 262 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 13 A 262 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 14 A 262 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 15 A 262 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 16 A 262 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 17 A 262 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 18 A 262 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 19 A 262 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 20 A 262 LYS GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY SEQRES 21 A 262 LEU SER SEQRES 1 B 262 SER MET PRO THR PRO GLU ALA PRO TYR ALA SER LEU THR SEQRES 2 B 262 GLU ILE GLU HIS LEU VAL GLN SER VAL SER LYS SER TYR SEQRES 3 B 262 ARG GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG SEQRES 4 B 262 GLN ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY SEQRES 5 B 262 TYR GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS SEQRES 6 B 262 ALA HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU SEQRES 7 B 262 PHE ALA LYS ARG LEU SER GLY PHE MET GLU LEU SER GLN SEQRES 8 B 262 ASN ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU SEQRES 9 B 262 VAL VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP SEQRES 10 B 262 ASN ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET SEQRES 11 B 262 GLU LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SEQRES 12 B 262 SER ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS SEQRES 13 B 262 PHE SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL SEQRES 14 B 262 LEU ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG SEQRES 15 B 262 LYS VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE SEQRES 16 B 262 HIS HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU SEQRES 17 B 262 ALA LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SEQRES 18 B 262 SER GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU SEQRES 19 B 262 HIS PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR SEQRES 20 B 262 LYS GLU LEU PHE SER THR GLU THR GLU SER PRO VAL GLY SEQRES 21 B 262 LEU SER HET XO5 A4001 62 HET XNX A4002 29 HET XO5 B4000 62 HET XNX B4001 29 HETNAM XO5 (1R,15S)-16-(CYCLOPROPYLACETYL)-5-FLUORO-20-METHYL- HETNAM 2 XO5 9LAMBDA~6~-THIA-1,8,16-TRIAZATRICYCLO[13.3.1.1~3, HETNAM 3 XO5 7~]ICOSA-3(20),4,6-TRIENE-9,9-DIONE HETNAM XNX 4-[1-(2,6-DICHLOROBENZOYL)-4-FLUORO-1H-INDAZOL-3- HETNAM 2 XNX YL]BENZOIC ACID FORMUL 3 XO5 2(C22 H32 F N3 O3 S) FORMUL 4 XNX 2(C21 H11 CL2 F N2 O3) FORMUL 7 HOH *191(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 ARG A 296 ASN A 298 5 3 HELIX 4 AA4 SER A 301 ARG A 310 1 10 HELIX 5 AA5 SER A 312 ARG A 337 1 26 HELIX 6 AA6 GLY A 340 LEU A 344 5 5 HELIX 7 AA7 SER A 345 MET A 365 1 21 HELIX 8 AA8 GLY A 384 GLY A 392 5 9 HELIX 9 AA9 CYS A 393 ALA A 409 1 17 HELIX 10 AB1 SER A 413 ILE A 426 1 14 HELIX 11 AB2 GLU A 435 THR A 457 1 23 HELIX 12 AB3 ARG A 459 LEU A 466 5 8 HELIX 13 AB4 GLY A 470 HIS A 490 1 21 HELIX 14 AB5 PHE A 498 SER A 507 1 10 HELIX 15 AB6 SER B 266 GLU B 283 1 18 HELIX 16 AB7 ARG B 288 GLN B 295 1 8 HELIX 17 AB8 ARG B 296 ASN B 298 5 3 HELIX 18 AB9 SER B 301 ARG B 310 1 10 HELIX 19 AC1 SER B 312 ARG B 337 1 26 HELIX 20 AC2 GLY B 340 LEU B 344 5 5 HELIX 21 AC3 SER B 345 MET B 365 1 21 HELIX 22 AC4 GLY B 384 GLY B 392 5 9 HELIX 23 AC5 CYS B 393 ALA B 409 1 17 HELIX 24 AC6 SER B 413 ILE B 426 1 14 HELIX 25 AC7 GLU B 435 THR B 457 1 23 HELIX 26 AC8 ARG B 459 LEU B 466 5 8 HELIX 27 AC9 PRO B 468 HIS B 490 1 23 HELIX 28 AD1 PHE B 498 PHE B 506 1 9 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SHEET 1 AA2 3 TYR B 369 ASN B 370 0 SHEET 2 AA2 3 THR B 375 PHE B 378 -1 O THR B 375 N ASN B 370 SHEET 3 AA2 3 LYS B 381 GLY B 383 -1 O LYS B 381 N PHE B 378 SSBOND 1 CYS A 455 CYS B 455 1555 1555 2.04 CRYST1 47.600 97.680 56.810 90.00 91.43 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021008 0.000000 0.000524 0.00000 SCALE2 0.000000 0.010238 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017608 0.00000